Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

NCT07675967 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT07675967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07675967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Lead sponsor
Dana-Farber Cancer Institute
Phase
Observational
Overall status
Recruiting
Start date
April 4, 2025
Completion date
March 31, 2035
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, clonal cytopenia of undetermined significance, clonal hematopoiesis of indeterminate potential (chip), colorectal (colon or rectal) cancer, endometrial adenocarcinoma, esophageal adenocarcinoma, gastric (stomach) cancer, head and neck cancer, lung cancer (diagnosis), osteochondroma, ovarian adenocarcinoma, sarcoma, solid cancers, spitz nevus, therapy-related acute myeloid leukemia, therapy-related mds, uterine adenocarcinoma